S&P 500   4,580.77 (+0.64%)
DOW   35,633.07 (+0.40%)
QQQ   382.38 (+0.63%)
AAPL   152.03 (+2.14%)
MSFT   322.29 (-0.27%)
FB   311.45 (-0.25%)
GOOGL   2,908.99 (-0.53%)
TSLA   1,061.50 (+2.28%)
AMZN   3,408.56 (+0.47%)
NVDA   246.67 (+0.88%)
BABA   169.85 (+0.37%)
NIO   39.63 (+0.81%)
CGC   12.96 (+1.41%)
GE   104.26 (+0.39%)
AMD   122.16 (-0.10%)
MU   69.82 (+2.32%)
T   25.51 (+1.80%)
F   17.06 (+9.99%)
ACB   6.93 (+1.32%)
DIS   169.77 (+0.13%)
PFE   43.22 (+0.58%)
BA   206.41 (-0.10%)
AMC   36.03 (+3.65%)
S&P 500   4,580.77 (+0.64%)
DOW   35,633.07 (+0.40%)
QQQ   382.38 (+0.63%)
AAPL   152.03 (+2.14%)
MSFT   322.29 (-0.27%)
FB   311.45 (-0.25%)
GOOGL   2,908.99 (-0.53%)
TSLA   1,061.50 (+2.28%)
AMZN   3,408.56 (+0.47%)
NVDA   246.67 (+0.88%)
BABA   169.85 (+0.37%)
NIO   39.63 (+0.81%)
CGC   12.96 (+1.41%)
GE   104.26 (+0.39%)
AMD   122.16 (-0.10%)
MU   69.82 (+2.32%)
T   25.51 (+1.80%)
F   17.06 (+9.99%)
ACB   6.93 (+1.32%)
DIS   169.77 (+0.13%)
PFE   43.22 (+0.58%)
BA   206.41 (-0.10%)
AMC   36.03 (+3.65%)
S&P 500   4,580.77 (+0.64%)
DOW   35,633.07 (+0.40%)
QQQ   382.38 (+0.63%)
AAPL   152.03 (+2.14%)
MSFT   322.29 (-0.27%)
FB   311.45 (-0.25%)
GOOGL   2,908.99 (-0.53%)
TSLA   1,061.50 (+2.28%)
AMZN   3,408.56 (+0.47%)
NVDA   246.67 (+0.88%)
BABA   169.85 (+0.37%)
NIO   39.63 (+0.81%)
CGC   12.96 (+1.41%)
GE   104.26 (+0.39%)
AMD   122.16 (-0.10%)
MU   69.82 (+2.32%)
T   25.51 (+1.80%)
F   17.06 (+9.99%)
ACB   6.93 (+1.32%)
DIS   169.77 (+0.13%)
PFE   43.22 (+0.58%)
BA   206.41 (-0.10%)
AMC   36.03 (+3.65%)
S&P 500   4,580.77 (+0.64%)
DOW   35,633.07 (+0.40%)
QQQ   382.38 (+0.63%)
AAPL   152.03 (+2.14%)
MSFT   322.29 (-0.27%)
FB   311.45 (-0.25%)
GOOGL   2,908.99 (-0.53%)
TSLA   1,061.50 (+2.28%)
AMZN   3,408.56 (+0.47%)
NVDA   246.67 (+0.88%)
BABA   169.85 (+0.37%)
NIO   39.63 (+0.81%)
CGC   12.96 (+1.41%)
GE   104.26 (+0.39%)
AMD   122.16 (-0.10%)
MU   69.82 (+2.32%)
T   25.51 (+1.80%)
F   17.06 (+9.99%)
ACB   6.93 (+1.32%)
DIS   169.77 (+0.13%)
PFE   43.22 (+0.58%)
BA   206.41 (-0.10%)
AMC   36.03 (+3.65%)
NASDAQ:SLHG

Skylight Health Group Stock Forecast, Price & News

$2.93
-0.01 (-0.34 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.88
$3.00
50-Day Range
$2.06
$3.55
52-Week Range
$2.00
$6.25
Volume
46,411 shs
Average Volume
61,787 shs
Market Capitalization
$113.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SLHG News and Ratings via Email

Sign-up to receive the latest news and ratings for Skylight Health Group and its competitors with MarketBeat's FREE daily newsletter.


About Skylight Health Group

Skylight Health Group, Inc. engages in the operation of a proprietary electronic health record system. It offers primary care, sub-specialty, allied health, laboratory and diagnostic testing, and subscription-based telemedicine service It operates through the United States and Canada segments. The company was founded by Pradyum Sekar and Kashaf Qureshi in 2014 and is headquartered in Mississauga, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SLHG
Employees
80
Year Founded
N/A

Sales & Book Value

Annual Sales
$9.81 million

Profitability

Net Income
$-7.08 million
Pretax Margin
-62.82%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$113.94 million
Next Earnings Date
11/29/2021 (Estimated)
Fiscal Year End
December 31
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

900th out of 1,372 stocks

Offices & Clinics Of Medical Doctors Industry

6th out of 11 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Skylight Health Group (NASDAQ:SLHG) Frequently Asked Questions

Is Skylight Health Group a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Skylight Health Group in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Skylight Health Group stock.
View analyst ratings for Skylight Health Group
or view top-rated stocks.

What stocks does MarketBeat like better than Skylight Health Group?

Wall Street analysts have given Skylight Health Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Skylight Health Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Skylight Health Group?

Skylight Health Group saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 134,400 shares, an increase of 27.0% from the September 15th total of 105,800 shares. Based on an average daily trading volume, of 54,200 shares, the days-to-cover ratio is currently 2.5 days. Currently, 0.5% of the company's stock are sold short.
View Skylight Health Group's Short Interest
.

When is Skylight Health Group's next earnings date?

Skylight Health Group is scheduled to release its next quarterly earnings announcement on Monday, November 29th 2021.
View our earnings forecast for Skylight Health Group
.

How were Skylight Health Group's earnings last quarter?

Skylight Health Group Inc. (NASDAQ:SLHG) posted its earnings results on Monday, August, 16th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company earned $8.56 million during the quarter. Skylight Health Group had a negative trailing twelve-month return on equity of 57.94% and a negative net margin of 63.94%.
View Skylight Health Group's earnings history
.

What price target have analysts set for SLHG?

4 brokers have issued 12 month price objectives for Skylight Health Group's stock. Their forecasts range from $7.00 to $9.00. On average, they expect Skylight Health Group's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 173.0% from the stock's current price.
View analysts' price targets for Skylight Health Group
or view top-rated stocks among Wall Street analysts.

Who are Skylight Health Group's key executives?

Skylight Health Group's management team includes the following people:
  • Pradyum Sekar, Chief Executive Officer, Secretary & Director
  • Mohammad Bataineh, President
  • Andrew Louis Elinesky, Chief Financial Officer
  • Kit Brekhus, Chief Medical Officer
  • Stephanie Gluchacki, Senior Vice President-Compliance

What is Skylight Health Group's stock symbol?

Skylight Health Group trades on the NASDAQ under the ticker symbol "SLHG."

How do I buy shares of Skylight Health Group?

Shares of SLHG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Skylight Health Group's stock price today?

One share of SLHG stock can currently be purchased for approximately $2.93.

How much money does Skylight Health Group make?

Skylight Health Group has a market capitalization of $113.94 million and generates $9.81 million in revenue each year. The company earns $-7.08 million in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does Skylight Health Group have?

Skylight Health Group employs 80 workers across the globe.

What is Skylight Health Group's official website?

The official website for Skylight Health Group is www.skylighthealthgroup.com.

How can I contact Skylight Health Group?

The company can be reached via phone at (855) 874-4999 or via email at [email protected].


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.